Sedation and memory: studies with a histamine H-1 receptor antagonist

Area of Science:

• Pharmacology
• Neuroscience
• Cognitive Psychology

Background:

• Sedating medications, such as H-1 receptor antagonists, are widely used.
• The impact of these drugs on cognitive functions, particularly memory, requires detailed investigation.
• Understanding the relationship between sedation and cognitive impairment is crucial for patient safety and drug development.

Purpose of the Study:

• To evaluate the influence of an H-1 receptor antagonist (diphenhydramine) and a benzodiazepine (lorazepam) on various cognitive functions.
• To determine if sedation is a prerequisite for drug-induced memory impairment.
• To explore the potential dissociation between sedation and memory effects.

Main Methods:

• A double-blind, placebo-controlled, crossover study involving 12 healthy volunteers.
• Administration of varying doses of diphenhydramine (50-100 mg) and lorazepam (0.5-1.5 mg).
• Assessment of subjective sedation, sleep latency, and cognitive tasks including digit symbol substitution, choice reaction time, sustained attention, and memory recall at multiple time points.

Main Results:

• Diphenhydramine caused dose-dependent subjective sedation and impaired performance on attention and reaction time tasks.
• Lorazepam (1.5 mg) induced sedation and impaired attention, reaction time, and memory recall, but not sleep latency.
• Both drugs impaired prompted recall at 2 hours post-ingestion; lorazepam showed slower response times on memory-related tasks.

Conclusions:

• Memory impairment from sedating drugs may not be directly linked to the level of sedation.
• Cognitive deficits, especially memory impairment, could involve neuronal systems distinct from those regulating arousal.
• Further research into the specific neurobiological pathways affected by these drugs is warranted.